2024 Global Infectious Disease Testing Market: Unmet Needs, Supplier Shares and Strategies, Segment Volume and Sales Forecasts for 100 Tests, Emerging Technologies and Trends, Instrumentation Pipeline, Growth Opportunities

August 2024 | - | ID: 241987183C98EN
Venture Planning Group

Abstracts

The new report from LeadingMarketResearch.com contains 1,954 pages, 824 tables and provides market segmentation analysis of over 100 diseases and viruses in seven countries, assessment of emerging technologies, review of current instrumentation, as well as strategic profiles of leading suppliers and recent market entrants with innovative technologies and products.The report is available by section, and can be customized to specific information needs and budget.RationaleThis comprehensive seven-country report is designed to assist diagnostics industry executives, as well as companies planning to diversify into the dynamic and rapidly expanding microbiology testing market, in evaluating emerging opportunities and developing effective business strategies.The microbiology testing market is one of the most rapidly growing segments of the in vitro diagnostics industry, and the greatest challenge facing suppliers. Among the main driving forces is continuing spread of AIDS, which remains the world's major health threat and a key factor contributing to the rise of opportunistic infections; threat of bioterrorism; advances in molecular diagnostic technologies; and wider availability of immunosuppressive drugs.Although for some infections the etiology is still a mystery, while for others the causative microorganisms are present in minute concentrations long before the occurrence of first clinical symptoms, recent advances in genetic engineering and detection technologies are creating exciting opportunities for highly sensitive, specific and cost-effective products.Geographic Coverage%li%France, Germany, Italy, Japan, Spain, UK, USAMarket Segmentation Analysis%li%Sales and market shares of major suppliers of microbiology products, by country and individual test.%li%Test and sales forecasts for over 100 microbiology assays by country, individual test and market segment:%li%Hospitals%li%Blood Banks%li%Commercial/Private Laboratories%li%Physician Offices/Group Practices%li%Public Health Laboratories%li%Review of market dynamics, trends, structure, size, growth and major suppliers by country.Current and Emerging Products%li%In-depth examination of over 100 major diseases, including etiology, current diagnostic tests, vaccines, drugs and market needs.%li%Review of major analyzers used for microbiology testing, including their operating characteristics, features and selling prices.Technology Review%li%Assessment of molecular diagnostic, monoclonal antibody, immunoassay, ; and other technologies and their potential applications for microbiology testing.%li%Extensive listings of companies developing or marketing microbiology products worldwide by individual test.Competitive Assessments%li%Detailed strategic assessments of 32 major suppliers and emerging market entrants, including their sales, product portfolios, marketing tactics, collaborative arrangements and new products in R&D.Worldwide Market Overview%li%Estimated universe of laboratories performing microbiology tests by country.%li%Test volume and sales projections for major microbiology assays by country.Opportunities and Strategic Recommendations%li%Emerging opportunities for new instrumentation, reagents, IT and other products with significant market appeal during the next five years.%li%Design criteria for decentralized testing products.%li%Alternative market penetration strategies.%li%Potential market entry barriers and risks.MethodologyThe report is based on a combination of primary and secondary information sources, including interviews with laboratory directors, and executives of leading diagnostics companies and start-up firms developing innovative products in the U.S., five major European countries and Japan. In addition to primary sources of information, a comprehensive review of the most recent technical and business publications, manufacturer product and financial literature, as well as LeadingMarketResearch.com's proprietary data files was conducted.Contains 1,954 pages and 824 tables

Contents

I. Introduction
II. Major Product Development Opportunities
A. Instrumentation
B. Reagent Kits and Test Systems/Panels
C. Information Technology
D. Auxiliary Products
III. Design Criteria for Decentralized Testing Products
IV. Alternative Market Penetration Strategies
A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies for Decentralized
Testing Markets
V. Potential Market Entry Barriers and Risks
A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges
VI. Worldwide Overview of Major Tests,
Technologies, and Instrumentation
A. Major Infectious Disease Tests

1. AIDS: HIV/HIV-1/2/COMBO, HIVAG/HIV NAT,

Western Blot, HTLV-I/II

2. ADENOVIRUS

3. AEROMONAS

4. ANTHRAX/BACILLUS ANTHRACIS

5. ARBOVIRUSES

6. BABESIOSIS

7. BACILLARY EPITHELIOID ANGIOMATOSIS (BEA)

and Other Bartonella (Rochalimaea)

8. BLASTOCYSTIS HOMINIS

9. BRUCELLA

10. CAMPYLOBACTER

11. CANDIDA

Table of Contents (continued)

12. CHAGAS DISEASE

13. CHANCROID

14. CHLAMYDIA

15. CLOSTRIDIUM DIFFICILE

16. CORONAVIRUSES

17. COXSACKIEVIRUSES

18. CREUTZFELDT-JAKOB’S DISEASE

19. CRYPTOSPORIDIUM PARVUM

20. CYCLOSPORA CAYETANENSIS

21. CYTOMEGALOVIRUS

22. EBOLA VIRUS

23. E. COLI

24. ECHOVIRUS

25. ENCEPHALITIS

26. ENTEROVIRUSES

27. EPSTEIN-BARR VIRUS

28. GIARDIA LAMBLIA

29. GONORRHEA

30. GRANULOMA INGUINALE

31. HANTAVIRUS

32. HELICOBACTER PYLORI

33. HEPATITIS: HAV NAT, HBV NAT, HBS AG, HCV, HCV NAT,

Anti-HBc, Anti-HBs, Anti-HAV, Hepatitis Delta, HBc Ag,
HBe Ag, ALT/SGPT

34. HERPES SIMPLEX VIRUS

35. HUMAN HERPES VIRUS-6 (HHV-6)

36. INFLUENZA VIRUSES

37. LEGIONELLA

38. LYME DISEASE

39. LYMPHOGRANULOMA VENEREUM (LGV)

40. MALARIA

41. MEASLES (RUBEOLA)

42. MENINGITIS

43. MICROSPORIDIUM

44. MONONUCLEOSIS

45. MUMPS

46. MYCOPLASMA

47. PAPILLOMAVIRUSES

48. PARVOVIRUS B19

49. PNEUMONIA

50. POLYOMAVIRUSES

51. PSEUDOMONAS AERUGINOSA

52. RABIES

53. RESPIRATORY SYNCYTIAL VIRUS (RSV)

54. RHINOVIRUSES

55. ROTAVIRUS